Zobrazeno 1 - 10
of 632
pro vyhledávání: '"Kouichi, Tamura"'
Autor:
Sho Shimamoto, Takako Nakahara, Shunsuke Yamada, Hajime Nagasu, Seiji Kishi, Naoki Nakashima, Kazuhiko Tsuruya, Hirokazu Okada, Kouichi Tamura, Ichiei Narita, Shoichi Maruyama, Yuichiro Yano, Takashi Yokoo, Takashi Wada, Jun Wada, Eiichiro Kanda, Hiromi Kataoka, Masaomi Nangaku, Naoki Kashihara, Toshiaki Nakano
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Chronic kidney disease-mineral and bone disorder (CKD-MBD) are recognized as a systemic disease affecting the prognosis of patients with CKD. Proper management of CKD-MBD is important to improve the prognosis of patients with CKD. Although p
Externí odkaz:
https://doaj.org/article/8f524f1ec6b846b390223610c261dc08
Autor:
Norihiro Tsuneyoshi, Tomonori Hosoya, Yuriko Takeno, Kodai Saitoh, Hidetaka Murai, Naoki Amimoto, Rie Tatsumi, Sono Watanabe, Yudai Hasegawa, Eri Kikkawa, Kumiko Goto, Fusako Nishigaki, Kouichi Tamura, Hironobu Kimura
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-20 (2024)
Abstract Background The human induced pluripotent stem cells (hiPSCs) can generate all the cells composing the human body, theoretically. Therefore, hiPSCs are thought to be a candidate source of stem cells for regenerative medicine. The major challe
Externí odkaz:
https://doaj.org/article/7bbef4cf76ae4912aa5b253dcb819c08
Publikováno v:
Kidney Medicine, Vol 6, Iss 11, Pp 100896- (2024)
Rationale & Objective: Allopurinol and febuxostat, which are xanthine oxidoreductase inhibitors, have been widely used as uric acid-lowering medications. However, evidence regarding their cardiovascular effects in hemodialysis is insufficient. This s
Externí odkaz:
https://doaj.org/article/339cbec8a00740ddb01c5984b332a710
Autor:
Kotaro Uchida, Lin Chen, Shintaro Minegishi, Takuya Sugawara, Rie Sasaki-Nakashima, Kentaro Arakawa, Hiroshi Doi, Tabito Kino, Naoki Tada, Sho Tarumi, Noriyuki Kawaura, Kouichi Tamura, Kiyoshi Hibi, Tomoaki Ishigami
Publikováno v:
Journal of Vascular Diseases, Vol 3, Iss 2, Pp 161-173 (2024)
The early diagnosis and appropriate treatment of subclinical atherosclerosis before the onset of life-threatening cardiovascular (CV) diseases are major unmet medical needs in current clinical practice. Noninvasive arterial stiffness indices, the art
Externí odkaz:
https://doaj.org/article/47302b6ff8614654a31c4c72ed74ba3b
Autor:
Zannatun Nyma, Kaori Kitaoka, Yuichiro Yano, Hiroshi Kanegae, Nomin Bayaraa, Seiji Kishi, Hajime Nagasu, Toshiaki Nakano, Jun Wada, Shoichi Maruyama, Naoki Nakagawa, Kouichi Tamura, Takashi Yokoo, Motoko Yanagita, Ichiei Narita, Kunihiro Yamagata, Takashi Wada, Kazuhiko Tsuruya, Naoki Nakashima, Yoshitaka Isaka, Masaomi Nangaku, Naoki Kashihara, Hirokazu Okada, J-CKD-DB study collaborative
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Understanding the association between compliance to the Chronic Kidney Disease (CKD) guidelines in real-world clinical settings and renal outcomes remains a critical gap in knowledge. A comprehensive analysis was conducted using data from a
Externí odkaz:
https://doaj.org/article/8d40de948dba409a944a7cf390865a53
Autor:
Kayo Waki, Mitsuhiko Nara, Syunpei Enomoto, Makiko Mieno, Eiichiro Kanda, Akiko Sankoda, Yuki Kawai, Kana Miyake, Hiromichi Wakui, Yuya Tsurutani, Nobuhito Hirawa, Tadashi Yamakawa, Shiro Komiya, Akihiro Isogawa, Shinobu Satoh, Taichi Minami, Tamio Iwamoto, Tatsuro Takano, Yasuo Terauchi, Kouichi Tamura, Toshimasa Yamauchi, Masaomi Nangaku, Naoki Kashihara, Kazuhiko Ohe
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-12 (2024)
Abstract We evaluated the effectiveness of a mobile health (mHealth) intervention for diabetic kidney disease patients by conducting a 12-month randomized controlled trial among 126 type 2 diabetes mellitus patients with moderately increased albuminu
Externí odkaz:
https://doaj.org/article/84d1a649ca5c4b8488247a76bd255375
Autor:
Yusuke Kobayashi, Keisuke Yatsu, Aiko Haruna, Rina Kawano, Moe Ozawa, Tatsuya Haze, Shiro Komiya, Shota Suzuki, Yuki Ohki, Akira Fujiwara, Sanae Saka, Nobuhito Hirawa, Yoshiyuki Toya, Kouichi Tamura
Publikováno v:
The Journal of Clinical Hypertension, Vol 26, Iss 4, Pp 355-362 (2024)
Abstract Single‐nucleotide polymorphisms (SNP) of ATP2B1 gene are associated with essential hypertension but their association with resistant hypertension (RHT) remains unexplored. The authors examined the relationship between ATP2B1 SNPs and RHT b
Externí odkaz:
https://doaj.org/article/cab2df7edd994d4695a4088fb82f2d41
Autor:
Kaori Kitaoka, Yuichiro Yano, Naoki Kashihara, Hajime Nagasu, Hiroshi Kanegae, Noriharu Chishima, Hiroki Akiyama, Kouichi Tamura
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 12, Iss 3 (2024)
Introduction We compared the kidney outcomes between patients with diabetic kidney disease (DKD) aged ≥75 years initiating sodium-glucose cotransporter 2 (SGLT2) inhibitors versus other glucose-lowering drugs, additionally presenting with or withou
Externí odkaz:
https://doaj.org/article/50468c8884714f01802f46f2ee41a345
Autor:
Natsuki Fukuda, Daisuke Kanai, Kaoru Hoshino, Yuriko Fukuda, Ryutaro Morita, Yuki Ishikawa, Tomohiko Kanaoka, Yoshiyuki Toya, Yohei Kirino, Hiromichi Wakui, Kouichi Tamura
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is caused by mutations in the ubiquitin-activating enzyme1 (UBA1) gene and characterised by an overlap between autoinflammatory and haematologic disorders.
Externí odkaz:
https://doaj.org/article/efb71c9a4ac44f5298a06eff4888568e
Autor:
Yoshimi Muta, Kazuo Kobayashi, Masao Toyoda, Atsuhito Tone, Daisuke Suzuki, Daisuke Tsuriya, Hideo Machimura, Hidetoshi Shimura, Hiroshi Takeda, Hisashi Yokomizo, Kei Takeshita, Keiichi Chin, Keizo Kanasaki, Kouichi Tamura, Masaaki Miyauchi, Masuo Saburi, Miwa Morita, Miwako Yomota, Moritsugu Kimura, Nobuo Hatori, Shinichi Nakajima, Shun Ito, Shunichiro Tsukamoto, Takashi Murata, Takaya Matsushita, Takayuki Furuki, Takuya Hashimoto, Tomoya Umezono, Yuichi Takashi, Daiji Kawanami
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Accumulating evidence has demonstrated that both SGLT2 inhibitors (SGLT2i) and GLP-1 receptor agonists (GLP1Ra) have protective effects in patients with diabetic kidney disease. Combination therapy with SGLT2i and GLP1Ra is commonly used in patients
Externí odkaz:
https://doaj.org/article/e387d4d5ba7242e08853f9abf1debf8d